10-Q: Alignment Healthcare Returns to Profitability with Strong Q2 2025 Revenue and Membership Growth

Alignment Healthcare, Inc. reported a significant return to net income for the second quarter and first half of 2025, driven by substantial Health Plan membership growth and an improved Medical Benefits Ratio.

Summary

• Achieved net income of $15.653 million for the three months ended June 30, 2025, a notable improvement from a net loss of $24.003 million in the same period last year.
• Reported net income of $6.299 million for the six months ended June 30, 2025, compared to a net loss of $70.578 million for the first half of 2024.
• Total revenues increased by 49.0% to $1,015.288 million for Q2 2025 and by 48.3% to $1,942.220 million for H1 2025.
• Health Plan membership grew by 27.8% year-over-year, reaching 223,700 members as of June 30, 2025.
• The Medical Benefits Ratio (MBR) improved to 86.7% for Q2 2025 (from 88.7% in Q2 2024) and 87.5% for H1 2025 (from 89.8% in H1 2024).
• Adjusted EBITDA surged to $45.913 million for Q2 2025 (from $6.034 million in Q2 2024) and $66.091 million for H1 2025 (from a loss of $5.946 million in H1 2024).
• Selling, general, and administrative expenses increased in absolute dollars but decreased as a percentage of revenue due to economies of scale.
• Interest expense decreased by 29.8% in Q2 2025 and 28.8% in H1 2025, primarily due to debt refinancing in November 2024, replacing higher-rate term loans with 4.25% convertible senior notes.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance, returning to profitability with substantial revenue and membership growth. Key metrics like MBR and Adjusted EBITDA showed significant improvement, and the successful refinancing of debt at a lower interest rate is a positive. While risks like the RADV audit and ongoing legal matters exist, the overall operational and financial trajectory is highly favorable.

Positives

• Returned to net income, reporting $15.653 million in Q2 2025 and $6.299 million in H1 2025, a significant turnaround from prior period losses.
• Achieved robust revenue growth of 49.0% in Q2 2025 and 48.3% in H1 2025, driven by increased membership and higher per-member revenue.
• Health Plan membership expanded by 27.8% year-over-year, reaching 223,700 members, indicating strong market penetration and retention.
• Improved Medical Benefits Ratio (MBR) to 86.7% in Q2 2025 and 87.5% in H1 2025, demonstrating effective cost management and clinical model efficiency.
• Adjusted EBITDA saw a substantial increase, reaching $45.913 million in Q2 2025 and $66.091 million in H1 2025, reflecting enhanced operational performance.
• Successfully refinanced debt in November 2024, reducing interest expense by replacing term loans with an average interest rate of 11.84% with 4.25% convertible senior notes.
• Demonstrated economies of scale, with selling, general, and administrative expenses decreasing as a percentage of revenue despite absolute increases.
• Maintained high quality ratings, with 100% of health plan members enrolled in plans rated 4 stars and above, and the California HMO plan achieving this rating for eight consecutive years.

Negatives

• Incurred a $0.6 million goodwill impairment expense related to the remeasurement of goodwill associated with one subsidiary during H1 2025.
• Experienced an increase in Part D cost sharing due to changes arising from the Inflation Reduction Act, contributing to higher medical expenses.
• Notified CMS of the discontinuation of participation in the ACO REACH model as of December 31, 2025, though the financial impact is expected to be immaterial.
• Incurred legal costs, including a tentative settlement of $913,000 for the Dabney class action lawsuit and $950,000 in settlement fees for the Maglione lawsuit.
• California HMO plan was selected for a Medicare Advantage contract-specific risk adjustment data validation (RADV) audit for payment year 2019, with potential for retrospective adjustments based on a revised methodology including extrapolated findings and no fee-for-service adjuster.

Risks

• History of net losses and the ability to achieve or maintain profitability in an environment of increasing expenses.
• Relatively limited operating history may affect investors' ability to evaluate the current business and future prospects.
• Viability of the growth strategy and the ability to realize expected results.
• Ability to attract new members and successfully enter new markets.
• Quality and pricing of products and services.
• Ability to maintain a high rating for health plans on the Five Star Quality Rating System.
• Ability to develop and maintain satisfactory relationships with care providers who service members.
• Ability to manage growth effectively, execute the business plan, maintain high levels of service and member satisfaction, or adequately address competitive challenges.
• Impact on the business of security breaches, loss of data, or other disruptions causing the compromise of sensitive information or preventing access to critical information.
• Impact on the business of disruptions in disaster recovery systems or management continuity planning.
• Cost of legal proceedings and litigation, including intellectual property and privacy disputes.
• Dependence on reimbursements by the Centers for Medicare and Medicaid Services (CMS) and premium payments by individuals.
• Other risks associated with being a government contractor.
• Impact on the business of the healthcare services industry becoming more cyclical.
• Ability to manage acquisitions, divestitures, and other significant transactions successfully.
• Ability to maintain, enhance, and protect reputation and brand recognition.
• Ability to effectively invest in, implement improvements to, and properly maintain the uninterrupted operation and data integrity of information technology and other business systems.
• Ability to obtain, maintain, protect, and enforce intellectual property protection for technology.
• Potential adverse impact of claims by third parties for infringing on, misappropriating, or otherwise violating their intellectual property rights.
• Impact of any restrictions on the use of or ability to license data or failure to license data and integrate third-party technologies.
• Dependence on the senior management team and other key employees.
• Concentration of health plans in a limited number of U.S. states.
• Management team's limited experience managing a public company.
• Ability to generate sufficient cash flow to service all indebtedness.
• Impact of shortages of qualified personnel and related increases in labor costs.
• Risk that records may contain inaccurate or unsupportable information regarding risk adjustment scores of members.
• Ability to accurately estimate incurred but not reported medical expenses.
• Impact of negative publicity regarding the managed healthcare industry.
• Impact of weather and other factors beyond control on clinics, external provider centers, and AVA platform facilities.
• Impact on the business of renegotiation, non-renewal, or termination of risk agreements with hospitals, physicians, nurses, pharmacists, and medical support staff.
• Risks associated with estimating the amount of liabilities recognized under risk agreements with providers.
• Ability to respond to general economic conditions, including increased inflation and higher interest rates.
• Risks associated with an economic downturn, including pressure on governmental budgets and reduced spending for health and human service programs.
• Ability to develop and maintain proper and effective internal control over financial reporting.
• Impact of state and federal efforts to reduce Medicare spending.
• Ability to comply with applicable federal, state, and local rules and regulations, including those relating to data privacy and security.
• An ownership change under IRC Section 382 could potentially limit the ability to utilize substantial net operating losses (NOLs).
• Uncertainty regarding the impact of the One Big Beautiful Bill Act (OBBB Act) on financial results.

Future Outlook

Expects continued significant member growth, particularly at the beginning of each calendar year. Anticipates per-member revenue to decline as new members join with less complete documentation and higher-revenue members are disproportionately impacted by senior mortality. Projects higher per-member medical costs in the first and fourth quarters due to seasonal illnesses. Foresees more moderate seasonality in prescription drug coverage starting in 2025 due to the Inflation Reduction Act. Corporate, general, and administrative expenses are expected to increase in absolute dollars to support ongoing growth. Plans to continue investments in the AVA platform, new market expansion, and innovative product offerings, potentially through strategic acquisitions of healthcare delivery groups, Medicare Advantage plans, and other complementary risk-bearing assets. Will discontinue participation in the ACO REACH model as of December 31, 2025, with an expected immaterial financial impact. Is currently evaluating the impact of the recently enacted One Big Beautiful Bill Act (OBBB Act) on financial results.

Management Comments

• Our ultimate goal is to bring this differentiated, advocacy-driven healthcare experience to millions of senior consumers in the United States and to become the most trusted senior healthcare brand in the country.
• Our model is based on a flywheel concept, referred to as our virtuous cycle, which is designed to delight our senior consumers.
• Our ability to manage healthcare expenditures while maintaining quality and member satisfaction is a distinct and sustainable competitive advantage.
• We believe that there are still significant opportunities for future growth even in some of our most mature markets where we have approximately 10-30% market share.
• We believe our ability to sustain MBR performance improvement over time positions us well to invest in new member growth to drive long-term financial performance.

Industry Context

Operates within the highly competitive U.S. Medicare Advantage sector, where growth is driven by the ability to offer superior value propositions and manage healthcare expenditures effectively. The business is significantly influenced by CMS regulations, including the Five Star Quality Rating System, which provides economic incentives for high-quality care and member satisfaction. The Inflation Reduction Act (IRA) is impacting Part D premium revenues and medical expenses, leading to changes in cost-sharing and benefit design. The company's participation in the CMS ACO REACH model is ending, reflecting strategic adjustments within the evolving healthcare landscape. Increased scrutiny from CMS through expanded Risk Adjustment Data Validation (RADV) audits, with new methodologies including extrapolation, poses a significant industry-wide challenge for Medicare Advantage plans.

Comparison to Industry Standards

• 100% of health plan members are enrolled in plans rated 4 stars and above, indicating a high-quality care experience as defined by CMS star measurement criteria, which is a strong competitive differentiator.
• The California HMO plan has consistently achieved a 4-star or greater rating for eight consecutive years, demonstrating sustained high performance in a key market.
• Routinely takes market share from large established players in highly competitive markets, leading to health plan membership growth in excess of the industry average.
• Holds approximately 5% market share of Medicare Advantage enrollees in its current markets as of June 30, 2025, indicating significant room for continued growth compared to larger, more established competitors.

Management Changes

Corporate Governance

Legal Proceedings

• Dabney v. Alignment Healthcare USA, LLC: A purported class action lawsuit filed April 27, 2022, alleging failure to provide hourly employees with required meal and rest breaks or pay premiums. A tentative settlement of $913,000 was reached on August 15, 2023, and is subject to court approval expected in Q3 2025.
• Maglione v. Alignment Healthcare, Inc., et al: A purported class action lawsuit filed July 7, 2023, alleging certain provisions of the stockholder agreement with General Atlantic and Warburg Pincus violated Delaware law. The company agreed to amend the stockholder agreement on April 30, 2024, to eliminate the challenged provisions, leading to the lawsuit's dismissal as moot on May 24, 2024. Settlement fees of $950,000 were paid in April 2025.
• Risk Adjustment Data Validation (RADV) Audit: The California HMO plan was selected for a RADV audit for payment year 2019 on June 25, 2025. CMS will apply a revised methodology, including extrapolated audit findings without a fee-for-service adjuster. CMS also announced a significant expansion of its RADV audit program. The company cannot reasonably estimate any retrospective adjustment or range of retrospective adjustment to prior payments as of June 30, 2025.

Related Party Transactions

• Amendment of the stockholder agreement with General Atlantic (GA) and Warburg Pincus to eliminate challenged provisions, which was a subject of the Maglione v. Alignment Healthcare, Inc., et al. lawsuit.

Stakeholder Impact

• Shareholders: Positively impacted by the return to profitability, strong revenue and membership growth, improved MBR, and reduced interest expense. Potential for future dilution from convertible notes if converted. Subject to potential financial impact from the RADV audit.
• Members (Seniors): Benefit from the company's focus on 'superior service, care and consumer satisfaction,' 'richer coverage and benefits,' and a 'high-quality care experience,' as evidenced by 100% of members being in 4-star and above plans.
• Employees: Affected by corporate restructuring efforts, which included severance costs. Equity-based compensation plans are in place.
• Care Providers: Engaged through contractual arrangements and capitation payments. Relationships with providers are critical, and potential renegotiation or termination of risk agreements could impact them.
• Government (CMS): The company's operations are highly dependent on CMS reimbursements and subject to various regulations, including risk adjustment models, minimum medical loss ratio (MLR) requirements, and ongoing RADV audits.

Next Steps

• Continue to invest in the proprietary AVA platform to enhance personalized care delivery and data analytics.
• Pursue new expansion opportunities and create innovative product offerings to meet evolving senior consumer needs.
• Potentially pursue strategic acquisitions, focusing on healthcare delivery groups in key geographies, standalone and provider-sponsored Medicare Advantage plans, and other complementary risk-bearing assets.
• Discontinue participation in the CMS ACO REACH model as of December 31, 2025.
• Monitor and evaluate the impact of the One Big Beautiful Bill Act (OBBB Act) on financial results.
• Continue to monitor changes in ownership to assess potential limitations on utilizing net operating loss (NOL) carryforwards under IRC Section 382.
• Await court approval for the tentative settlement of the Dabney v. Alignment Healthcare USA, LLC class action lawsuit, expected in Q3 2025.
• Collect and review medical records for the payment year 2019 Medicare Advantage contract-specific risk adjustment data validation (RADV) audit.

Key Dates

Recommendation

The company has demonstrated a significant turnaround, achieving profitability in Q2 and H1 2025 after prior losses. This is driven by exceptional revenue growth (nearly 50% YoY), robust membership expansion (27.8%), and a notable improvement in the Medical Benefits Ratio (MBR), indicating effective cost management. The successful refinancing of high-interest debt with lower-rate convertible notes further strengthens the financial position. While the RADV audit presents a potential future liability, the current operational momentum, strong market share gains, and consistent high CMS Star Ratings suggest a compelling growth trajectory and competitive advantage in the Medicare Advantage market. The company's 'virtuous cycle' model appears to be delivering tangible results, making it an attractive investment.

Keywords

Medicare Advantage, Healthcare, Health Plan, Managed Care, Risk Adjustment, Medical Benefits Ratio, Q2 2025 Earnings, 10-Q Filing, Health Technology, AVA Platform, CMS, Inflation Reduction Act, Convertible Senior Notes, Financial Results, Membership Growth